President and Chief Executive Officer
Geno is a 30 year veteran of the pharmaceutical and Life Sciences industry and was most recently President of Intrexon, a leader in the application of synthetic biology across a broad range of market segments.
Mr. Germano has held multiple high level roles at some of the world's largest and most innovative companies, including Pfizer, Johnson & Johnson and Wyeth. Mr. Germano led Pfizer's Global Innovative Pharmaceutical Business, cultivating a $14 billion operation and guiding the development of an extensive portfolio of products in the cardiovascular, immunology, metabolic disease, neuroscience and rare disease areas. Previously, he was President and General Manager of Pfizer's Specialty Care, Vaccines and Oncology business units.
Prior to joining Pfizer, Mr. Germano held numerous executive and leadership roles at Wyeth Pharmaceuticals including President of Wyeth U.S., President of Global Pharmaceutical and Women's Healthcare Business and Executive Vice President of the Vaccines Business. He has been a member of the Group of Fifty (G50) and served on the Board of the Biotechnology Innovation Organization, where he was a member of the Executive Committee. He continues to serve on the Advisory Board of the Healthcare Businesswomen's Association and is a Director of Sage Therapeutics (NASDAQ:SAGE) and The Medicines Company (NASDAQ:MDCO). Mr Germano received his Bachelor of Sciece degree at the Albany College of Pharmacy and Health Sciences.